Virology News and Research

Latest Virology News and Research

Intellimedix brings new approach to solve Ebola outbreak

Amidst the Ebola outbreak and subsequent research efforts, Atlanta-based Intellimedix is bringing a new approach to the table. Classical methods of drug development involve performing many experiments only to identify new molecules with a few desired effects.

16 Oct 2014

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

For many months, the world has witnessed the Ebola virus spread and claim more than 4,400 lives in West African countries. On Oct. 8, the first confirmed adult Ebola patient identified in the United States died. The constant news coverage has heightened concern among parents who fear their children will become infected. Jill Hoffman, MD, a pediatric Infectious diseases specialist at Children's Hospital Los Angeles, discusses the facts about Ebola, how parents can help their children prevent further outbreak by teaching them good hygiene, and how CHLA is prepared to identify and treat suspected Ebola patients.

16 Oct 2014

Myths, misconceptions about seasonal flu and flu vaccine

It's that time of year again. As days shorten, evenings become chilly and the trees start a showy display of color, it's time to roll up your sleeve and get your annual flu vaccine.

16 Oct 2014

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

16 Oct 2014

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

Foreign-born residents with low vaccination rates and their relatives in the U.S. are at greater risk of exposure to several vaccine-preventable diseases, e.g. influenza; pneumococcal diseases; tetanus, diphtheria and pertussis; hepatitis A; hepatitis B; shingles; and HPV, the human papilloma virus, which can lead to some types of cancer.

16 Oct 2014

New study suggests that 21-day quarantine period not enough to completely prevent Ebola

As medical personnel and public health officials are responding to the first reported cases of Ebola Virus in the United States, many of the safety and treatment procedures for treating the virus and preventing its spread are being reexamined. One of the tenets for minimizing the risk of spreading the disease has been a 21-day quarantine period for individuals who might have been exposed to the virus. But a new study by Charles Haas, PhD, a professor in Drexel's College of Engineering, suggests that 21 days might not be enough to completely prevent spread of the virus.

16 Oct 2014

Statement on Ebola epidemic

The Ebola virus is spreading rapidly and to an unexpected extent. The outbreak does not follow the patterns experienced in the past and the virus shows a new disease dynamic in regions, where it has never been recorded before. For this reason, the German National Academy of Sciences Leopoldina, acatech – the German Academy of Science and Engineering, and the Union of the German Academies of Sciences and Humanities have presented a statement on the Ebola epidemic today.

16 Oct 2014

New study reveals ways to reduce HIV rates in Mexico

To address the HIV epidemic in Mexico is to address it among men who have sex with men (MSM), because they account for a large percentage of the country's new infections, says Omar Galárraga, assistant professor of health services policy and practice in the Brown University School of Public Health.

16 Oct 2014

Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Understandably, the specter of such a dangerous disease in the United States has bred fear. But it is remarkable how some public figures are inflaming that fear. Commentator Rush Limbaugh took flight on Tuesday, saying on the radio that "I don't think anybody involved with Ebola knows what they're doing. I don't care if it's the WHO or the Centers for Disease Control, I don't think anybody knows what they're doing." This was an unfounded rant that can only deepen public disquiet.

16 Oct 2014

Promising vaccination strategy to counteract RSV

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.

16 Oct 2014

Columbia University professor recommends vaccination for people travelling abroad

Planning to travel outside the U.S. this holiday season? Check with your primary care provider or travel clinic when you book your flight.

16 Oct 2014

Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

A study recently published in the Journal of the American Academy of Dermatology shows that for Ebola, measles, syphilis and many other conditions with skin manifestations the mortality rates are hundreds of times higher in developing countries than they are in developed countries.

16 Oct 2014

Second Dallas health worker has Ebola; CDC announces 'more robust' response

Seventy-six health-care workers who helped treat Ebola patient Thomas Eric Duncan are now being monitored for potential Ebola exposure. Forty-eight others are being watched because they had contact with Duncan.

16 Oct 2014

Four out of ten children in Burkina Faso genetically resistant to virus strains

Every year rotavirus causes half a million diarrhoea-related deaths amongst children in developing countries. Existing vaccines provide poor protection. The reason could be a widespread genetic resistance amongst children, according to virologists at Linköping University.

15 Oct 2014

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

As recently as April, Obamacare was going to be the silver bullet for Republicans in this year's midterm elections. The leader of conservative advocacy group Americans for Prosperity said his plan was to make Obamacare "the No. 1 issue in the country." Senate Minority Leader Mitch McConnell, R-Ky., declared that the law would be "a huge disaster in 2014" and the deciding factor in November. Well, that was then. Now, three weeks from Election Day, some GOP challengers trying to knock off Democratic incumbent senators have scaled back their anti-Obamacare ads in favor of new targets such as the economy and national security (10/13).

15 Oct 2014

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

Virology News and Research

Latest Virology News and Research

Intellimedix brings new approach to solve Ebola outbreak

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

Myths, misconceptions about seasonal flu and flu vaccine

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

New study suggests that 21-day quarantine period not enough to completely prevent Ebola

Statement on Ebola epidemic

New study reveals ways to reduce HIV rates in Mexico

Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Promising vaccination strategy to counteract RSV

Columbia University professor recommends vaccination for people travelling abroad

Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

Second Dallas health worker has Ebola; CDC announces 'more robust' response

Four out of ten children in Burkina Faso genetically resistant to virus strains

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Researchers awarded grant to develop non-invasive device to detect Human Cytomegalovirus

CDC re-evaluating safety procedures after nurse contracts Ebola

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Ampro Industries spreads HIV/AIDS awareness through "A Positive Message" campaign

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production